# Safety, PK and PD of FLQ-101 in Premature Neonates

> **NCT07093255** · PHASE1 · RECRUITING · sponsor: **FELIQS INC.** · enrollment: 18 (estimated)

## Conditions studied

- Retinopathy of Prematurity (ROP)

## Interventions

- **DRUG:** FLQ-101

## Key facts

- **NCT ID:** NCT07093255
- **Lead sponsor:** FELIQS INC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07093255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07093255, "Safety, PK and PD of FLQ-101 in Premature Neonates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07093255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*